< Back to front page Text size – +

In case you missed it: hospital efficiency, Genzyme drug

E-mail | Print | Comments () Posted by Elizabeth Cooney August 31, 2009 07:26 AM

Facebook
E-mail

In the Sunday Globe:

"Death panels" may get more public attention in the American health care debate, but poor management at many of the nation’s 5,700 hospitals is a vastly more important reason that US health care costs are the highest in the world, and why the quality of care that we get for our money isn’t far better. But in recent years Boston University efficiency expert Eugene Litvak - originally trained in the Soviet Union, land of legendary inefficiency - has been proving that hospitals don’t have to be wasteful and inflexible.

In Saturday's Globe:

Just days before a key meeting to consider Genzyme Corp.’s application for a new leukemia drug to treat older patients, the Food and Drug Administration released a briefing document criticizing the Cambridge biotechnology company’s clinical study of the drug, called Clolar.

Facebook
E-mail

« Back to front page

About white coat notes

White Coat Notes covers the latest from the health care industry, hospitals, doctors offices, labs, insurers, and the corridors of government. Chelsea Conaboy previously covered health care for The Philadelphia Inquirer. Write her at cconaboy@boston.com. Follow her on Twitter: @cconaboy.

Daily Dose | More Health&Wellness

health answers

Long-term health consequences to being born prematurely? It's estimated that each year nearly 500,000 babies in the United States are born prematurely, or before 37 weeks of pregnancy. Submit question | More answers